10x Genomics ROA 2018-2024 | TXG
10x Genomics ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2024-09-30 | $-0.18B | $0.94B | -19.49% |
2024-06-30 | $-0.24B | $0.93B | -25.48% |
2024-03-31 | $-0.26B | $0.92B | -27.59% |
2023-12-31 | $-0.26B | $0.97B | -26.03% |
2023-09-30 | $-0.22B | $0.95B | -22.40% |
2023-06-30 | $-0.17B | $0.99B | -17.08% |
2023-03-31 | $-0.17B | $1.01B | -17.22% |
2022-12-31 | $-0.17B | $1.03B | -16.38% |
2022-09-30 | $-0.17B | $1.00B | -16.52% |
2022-06-30 | $-0.14B | $1.00B | -14.05% |
2022-03-31 | $-0.09B | $1.00B | -8.82% |
2021-12-31 | $-0.06B | $1.02B | -5.89% |
2021-09-30 | $-0.46B | $0.99B | -47.35% |
2021-06-30 | $-0.51B | $0.98B | -51.74% |
2021-03-31 | $-0.53B | $0.95B | -60.87% |
2020-12-31 | $-0.54B | $0.93B | -68.63% |
2020-09-30 | $-0.13B | $1.04B | -18.86% |
2020-06-30 | $-0.08B | $0.58B | -17.34% |
2020-03-31 | $-0.05B | $0.61B | -16.12% |
2019-12-31 | $-0.03B | $0.61B | -21.12% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.732B | $0.619B |
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $9.226B | 0.00 |
Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
Enovis (ENOV) | United States | $2.608B | 17.68 |
Privia Health (PRVA) | United States | $2.587B | 215.60 |
IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
Azenta (AZTA) | United States | $2.209B | 110.15 |
Omnicell (OMCL) | United States | $2.116B | 69.23 |
Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
Schrodinger (SDGR) | United States | $1.518B | 0.00 |
Phreesia (PHR) | United States | $1.148B | 0.00 |
Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
Standard BioTools (LAB) | United States | $0.596B | 0.00 |
Talkspace (TALK) | United States | $0.583B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
Pulmonx (LUNG) | United States | $0.268B | 0.00 |
TruBridge (TBRG) | United States | $0.247B | 71.91 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
American Well (AMWL) | United States | $0.124B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
HeartBeam (BEAT) | United States | $0.074B | 0.00 |
111 (YI) | China | $0.052B | 0.00 |
CareCloud (CCLD) | United States | $0.046B | 0.00 |
Outset Medical (OM) | United States | $0.044B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
Zepp Health (ZEPP) | China | $0.037B | 0.00 |
Movano (MOVE) | United States | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |